Gene Therapy for Chronic Granulomatous Disease

NCT00564759 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Granulomatous Disease, Chronic

Interventions

DRUG: retroviral SF71-gp91phox transduced CD34+ cells

Sponsor

Johann Wolfgang Goethe University Hospital

Collaborators

[object Object]